NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its fourth quarter revenues rose 15 percent year over year thanks largely to an uptick in testing revenues.

For the three months ended Dec. 31, the diagnostics company said Q4 2017 revenues rose to $12.5 million from $10.9 million in Q4 2016, beating analysts' average estimate of $12.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.